mohamed

Minnesota Chapter of the American Academy of Pediatrics

Casey Hokanson, BA, Zeinab Mohamud, BA, Janna Gewirtz O’Brien, MD, MPH



In Minnesota, nearly 6,000 youth experience homelessness each night. Trauma and marginalization are often causes of homelessness. Many have been harmed by systemic racism and identity-based oppression leading to stark disparities in the composition of youth experiencing homelessness (YEH) in Minnesota. 73% identify as BIPOC and 23% identify as LGBTQ+. Marginalization and oppression lead to health risks including trauma, injury, abuse, mental health risk, STIs, unplanned pregnancy, untreated medical conditions, substance use, and inadequate access to basic needs including housing, food, and healthcare access. Despite the many challenges YEH face, they display remarkable and inspiring resilience.



We would like to preface by emphasizing that housing is health. It is important for YEH’s basic needs to be met first before they access health. If you come into contact with a YEH who needs shelter, you can help them by bringing ysnmn.org to their attention. This resource that allows YEH to know which resources and shelters are in the community also comes as an app for easier access.



In our lab’s youth participatory action research, YEH identified barriers to navigating complex health systems. We offer some tips on how to overcome these barriers. Remember, although youth experiencing homelessness have a legal right to consent to their own healthcare, even as minors, when they are living apart from their legal guardian(s) and managing their own financial affairs, youth face many challenges accessing care. The last barrier encompasses supporting youth in owning their own healthcare. 



How can you as a healthcare provider do this?



<ul class="wp-block-list">
<li>Help them know their own medical conditions, medications, and allergies (use their phones, devices, or Health apps).</li>



<li>Encourage them to take pictures of their health insurance cards and vital documents so they have easier access to them.</li>



<li>Share employment opportunities, education and healthcare.</li>



<li>Know their healthcare team and how to reach them.</li>



<li>Ensure they have MyChart/electronic health record access.</li>



<li>Encourage regular checkups. Set up a follow-up before they leave the office or hospital.</li>



<li>Write down any questions or concerns they have between visits.</li>



<li>Help them understand their legal rights to accessing healthcare and shelter.</li>
</ul>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="387" src="https://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Teal-Peach-Lilac-Modern-Playful-Productivity-Tips-Infographic-Instagram-Post-2-1024x387.png" alt="" class="wp-image-4577" srcset="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Teal-Peach-Lilac-Modern-Playful-Productivity-Tips-Infographic-Instagram-Post-2-1024x387.png 1024w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Teal-Peach-Lilac-Modern-Playful-Productivity-Tips-Infographic-Instagram-Post-2-300x113.png 300w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Teal-Peach-Lilac-Modern-Playful-Productivity-Tips-Infographic-Instagram-Post-2-768x290.png 768w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Teal-Peach-Lilac-Modern-Playful-Productivity-Tips-Infographic-Instagram-Post-2-1536x581.png 1536w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Teal-Peach-Lilac-Modern-Playful-Productivity-Tips-Infographic-Instagram-Post-2.png 2000w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



As a healthcare provider, you are a leader in dismantling health inequities and forging positive relationships with youth. It takes a trauma-informed approach, cultural humility, and gentle patience to rebuild this bridge and trust between healthcare providers and youth experiencing homelessness.

Caring for Youth Experiencing Homelessness

Minnesota’s newborn screening panel is expanding with the addition of guanidinoacetate methyltransferase (GAMT) deficiency, Mucopolysaccharidosis Type II (MPS II), and Krabbe disease.



Following the recommendation of the Newborn Screening Advisory Committee, Minnesota Commissioner of Health Dr. Brooke Cunningham has approved these conditions for routine screening of newborns in the state. 



Commissioner Cunningham has directed the Newborn Screening program to initiate the necessary steps for implementing screening protocols for GAMT deficiency, MPS II, and Krabbe disease, underscoring the commitment to early detection and intervention for these rare genetic disorders.



For more information, visit: <a href="https://www.health.state.mn.us/people/newbornscreening/program/newbornscreeningpanel.html">https://www.health.state.mn.us/people/newbornscreening/program/newbornscreeningpanel.html</a>

Newborn Screening Panel Updates

Anti-Racism &amp; Health Equity



The Anti-racism and Health Equity workgroup is currently working on ways to connect with other state chapters who are doing work similar to ours, and networking with them to strengthen the goals we have.



We will also finalize work over the next few months with our YWCA equity consultant to review our chapter’s strategic planning for improved health equity in our chapter and across the state. Our next meeting is Monday, June 10, from 12:15 pm -1:00 pm.



If you are interested in joining the Anti-Racism &amp; Health Equity Work Group, email Jeff Bauer bauer@mnaap.org to be added to the group’s email list for upcoming meeting dates and activities.



Early Childhood



The Early Childhood Work Group has been meeting monthly and supporting lectures devoted to the topic of early childhood which are located on the AAP website. Our presenters have included Erin Bailey, Keriann Mahon, Andre Dukes, and Ariel Handevidt speaking on topics such as early relational health, the Northside Achievement Zone and the Children’s Cabinet. The work group is also tracking and supporting activities such as early literacy, the Early Childhood Family Education program, parent-child relational health, and infant mental health. 



Additionally, the work group’s recent activities include legislative tracking and advocacy. The primary early childhood initiatives this legislative session have been directed to supporting the changes and programs funded in the ‘23 budget session&#8211;with attention to thenestablishment of the new Executive Department of Children, Youth and Families.



We are hoping that other AAP fellows will join us in this work for the crucial birth to preschool children we care for. Please Contact Krish Subrahmanian at subrahm2003@gmail.com or Roger Sheldon at rogeugshe@gmail.com to join the group.

Work Group Updates | Spring 2024

Pat McKone, American Lung Association 



E-cigarettes are addicting a new generation to nicotine. Since 2014, e-cigarettes have been the #1 tobacco products used by youth. It’s a crisis of youth addiction that is a result of thousands of kid-friendly flavors and massive doses of nicotine.



The 2023 National Youth Tobacco Survey (NYTS) reported over 2.1 million kids used these devices in 2023. It is estimated more than 4,300 kids (under 18) try e-cigarettes daily.



Scope of the problem:



<ol class="wp-block-list">
<li>Many youth are using these products most days or every day, a sign they are becoming addicted. More than 70 percent of youth who use e-cigarettes in MN show signs of nicotine dependence.</li>



<li>Flavors are at the core of this problem. Close to 90% of youth use flavored products – fruit, candy, sweet, mint and menthol among the most popular. In Minnesota, one in seven 11th graders uses e-cigarettes, and 88 percent of those students use flavored e-cigarettes.</li>



<li>Disposable and menthol e-cigarettes are on the rise, two categories of products that were left behind under current federal regulation.</li>
</ol>



Resources for youth, parents and educators:



<ul class="wp-block-list">
<li>American Academy of Pediatrics &#8211; https://www.aap.org/en/patient-care/tobacco-control-and-prevention/e-cigarettes-and-vaping/</li>



<li>American Lung Association – www.lung.org </li>



<li>My Life My Quit – www. mylifemyquit.com </li>



<li>Truth Initiative – This is Quitting www.truthinitiative.org/our-top-issues/vaping-issue</li>



<li>Campaign for Tobacco Free Kids –www.tobaccofreekids.org</li>
</ul>

What’s New With Vaping?

<img loading="lazy" decoding="async" class="size-medium wp-image-4566 alignleft" src="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Headshot-300x300.jpeg" alt="" width="300" height="300" srcset="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Headshot-300x300.jpeg 300w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Headshot-150x150.jpeg 150w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Headshot.jpeg 500w" sizes="(max-width: 300px) 100vw, 300px" />Please welcome Hanna Jorgenson as our new Communications Manager!
Hanna comes to us with a wealth of marketing and communications experience in both the non-profit sector and the medical device industry. With a genuine passion for the mission of the American Academy of Pediatrics, she brings a unique blend of professional expertise and personal dedication to the table.
Having navigated the challenges of childhood cancer firsthand, she is intimately acquainted with the critical importance of our mission. Diagnosed with osteosarcoma at the age of 16, and later with Li-Fraumeni syndrome, a cancer predisposition syndrome, she understands the significance of early intervention and advocacy for young patients’ health.
Driven by a deep-seated commitment to improving the lives of young people, she has dedicated considerable time and energy to serving on various non-profit boards and volunteering with organizations focused on pediatric health and well-being. With boundless enthusiasm and a steadfast dedication to our cause, Hanna is poised to lead our communications efforts with creativity, compassion, and purpose!
You can reach Hanna at hanna@mnaap.org.

Welcome, Hanna!

<img loading="lazy" decoding="async" class="wp-image-4563 alignleft" src="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Chad-Fahning-300x300.jpg" alt="" width="213" height="213" srcset="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Chad-Fahning-300x300.jpg 300w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Chad-Fahning-150x150.jpg 150w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Chad-Fahning.jpg 482w" sizes="(max-width: 213px) 100vw, 213px" />Over 130 pediatricians, residents, and medical students flooded the hallways of the Capitol on March 13, as part of Pediatricians’ Day at the Capitol. Attendees heard from guest legislators at a midday program before embarking out to meet with their own legislators to discuss policy proposals that prioritize the health, safety, and wellness of kids.
The number of active bills MNAAP is fewer than the unprecedented plethora of MNAAP-backed bills passed in 2023. Nonetheless, if they find their way through the finish line, the large handful of policies championed by pediatricians this session will do innumerable good for the next generation of Minnesotans. Chiefly among these policies is legislation to allow childcare centers to require that participants meet the state’s vaccination requirements, to remedy the declining rate of childhood vaccinations witnessed nationwide. Pediatricians also put their stamp of approval on a bill to establish health standards in school curriculum statewide and legislation introducing a childcare tax credit, which would kick in next year. Additionally, legislation to reduce death and injury from unsecured firearms through safe storage requirements is making its way through pivotal Senate committees, despite being shunned from such committees last session. Lastly, MNAAP is supporting legislation to prohibit prior authorization for substance-use disorder treatment, outpatient mental health treatment, pediatric hospice care, and treatment for neonatal abstinence syndrome, as well as a proposed insurance mandate to provide coverage for gender-affirming care, additional postpartum care, and in vitro fertilization (IVF), among others.
These efforts are designed to improve access to patient care and are all the table as we near the end of the legislative session. 2024 is a non-budget year, so there is no requirement for lawmakers to pass anything this year (odd-year sessions carry a constitutional requirement to pass a balanced state budget). Nonetheless, legislative leadership struck a supplemental budget agreement with the Governor to add $477.5 million to the 2024-2025 biennial budget and another $62.7 million for the next fiscal biennium. $34 million of that is earmarked for additional state investment for children and families. The targets were agreed to after Minnesota Management and Budget (MMB) announced a $3.7 billion state budget surplus, with the caveat that state spending is projected to exceed revenues by $1.5 billion in the years ahead. MMB cited long- term spending increases as the chief cause of the projected deficit. The 2024-2025 budget deal passed last year saw a $20 billion increase in the total state budget, including a record $1.2 billion in new early childhood investments and over $2 billion in additional K-12 spending.
Only weeks remain for legislators to decide what to include in larger omnibus packages. Given the limited spending targets, many efforts with a fiscal impact will not survive the final days. The legislature is required to adjourn sine die no later than May 20, which will officially mark the end of the 2023- 2024 biennium. Even if nothing were to pass before then – an extremely unlikely prophecy – the 93rd legislature will be remembered as one of the most influential and impactful ones in recent memory.
In the interim, Minnesotans will indicate their approval or disapproval of legislative decision-making after two years of unilateral DFL control. Every seat in the Minnesota House of Representatives, or 2/3 of the total legislature, will be up for election on November 5 and the 94th legislature will convene thereafter in January.

2024 Legislative Session: Spring Update

<img loading="lazy" decoding="async" class="wp-image-4559 alignleft" src="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.31.52 AM-208x300.png" alt="" width="193" height="278" srcset="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.31.52 AM-208x300.png 208w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.31.52 AM.png 225w" sizes="(max-width: 193px) 100vw, 193px" />I recently read an article in the New York Times about an account on X (formerly known as Twitter) where a child policy consultant, with a background in early childhood, comments about child development. The account posts videos from public social media accounts with commentary on developmental milestones as well as the fascinating learning that babies and young children are doing every day. From language skills to social connections to the importance of play (instead of screens), the videos highlight what every pediatrician knows-that kids are amazing!


The videos shared in the article are so good in so many ways. Equally important is the commentary about what skills you can nurture or just to recognize your child’s unique ability to learn by curiosity and how much is gained from human-to-human connection.



The videos are such good examples of everyday interactions. Many of them capture the exact moment of realization; the second the child accomplishes the “thing”, whether reciprocal verbalization, overcoming their fear of jumping into water or getting the strawberry piece onto the spoon and into their mouths.



As a bonus, the videos show experiences that don’t require fancy educational toys. Many of the videos are of parents/grandparents/aunties/uncles spending time with a baby or young child talking, singing or reading to them. I’m sure you experience and probably model these strengths for families every day in your offices. The article, X account and accompanying videos remind me, yet again, of the tremendous privilege and joy it is to work with children and their families. The trust and relationships that each of us builds, over many years, is what makes the practice of pediatrics the best.



<a href="https://x.com/DanWuori/status/1764282393634988091">Watch the video here. </a>

Word from the President: Eileen Crespo, MD, FAAP

<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="770" height="1020" src="https://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.12.31 AM-1.png" alt="" class="wp-image-4553" srcset="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.12.31 AM-1.png 770w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.12.31 AM-1-226x300.png 226w, http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Screenshot-2024-05-23-at-9.12.31 AM-1-768x1017.png 768w" sizes="(max-width: 770px) 100vw, 770px" /></figure>
</div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<a href="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/06/Final-Spring-2024.pdf">Spring 2024 Minnesota Pediatrician PD</a><a href="https://wp.mnaap.org/wp-lib/wp-content/uploads/2024/06/Final-Spring-2024.pdf">F</a>



<a href="https://wp.mnaap.org/word-from-the-president-eileen-crespo-md-faap-5/">Word from the President: Eileen Crespo, MD, FAAP</a>



<a href="https://wp.mnaap.org/2024-legislative-session-spring-update/">2024 Legislative Session: Spring Update</a>



<a href="https://wp.mnaap.org/welcome-hanna/">Welcome, Hanna</a>



<a href="https://wp.mnaap.org/whats-new-with-vaping/">What&#8217;s New With Vaping</a>



<a href="https://wp.mnaap.org/work-group-updates-spring-2024/">Work Group Updates </a>



<a href="https://wp.mnaap.org/newborn-screening-panel-updates/">Newborn Screening Updates </a>



<a href="http://wp.mnaap.org/wp-lib/wp-content/uploads/2024/05/Measles-One-Pager-4.22.24.pdf">Think Measles </a>



<a href="https://wp.mnaap.org/caring-for-youth-experiencing-homelessness/">Caring for Youth Homelessness</a>
</div>
</div>

Spring 2024 Minnesota Pediatrician

Physicians and clinic staff interested in tracking viral respiratory illness trends this season, can make use of a new webpage created to offer an improved overview.
MDH launched the <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUa7R-Wup8lh40knGILLsONMGEeIMcu7EJmeAXTh_Co6jUfTVTddoxqXqjCQmf4AOwG7pXAsz9CTNMtaLwfWl3xO8zYV_esaOY6sY4Ki-8IyqPRm5En_RDcq-vsP5V76ojE0Ku7zMpVAnrLMBvKIwYyyg==&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUa7R-Wup8lh40knGILLsONMGEeIMcu7EJmeAXTh_Co6jUfTVTddoxqXqjCQmf4AOwG7pXAsz9CTNMtaLwfWl3xO8zYV_esaOY6sY4Ki-8IyqPRm5En_RDcq-vsP5V76ojE0Ku7zMpVAnrLMBvKIwYyyg%3D%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw1K3DdIZGgorNyC24pH_lGO">Viral Respiratory Illness in Minnesota (Data &amp; Statistics) </a>page as a one-stop shop for viral respiratory disease data. The page currently has interactive data on hospitalizations due to COVID-19, influenza, and RSV for the seven-county metropolitan area (among children and adults). In the coming weeks and months, MDH will add data to provide more information on circulating viral respiratory diseases.
The full <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUa470AkWsCye1ouQoujjbTFJRBGX7P1A5GTrRhK2xI7rBB1bYEmu42iDyLTcmH0r5yG8DhFhgT_JPLn2o7jNnF7TwV3XWPByihyaXWdjX5cCDhgTof-gdGYnxzdf-pmnH1Kj2_eQOngoGufAq0MJB1Z2Y1CK45KArreUEMuu4BWkSyU1Fu1ITIa3rQ8EumOG3ilbMvr4Md20ka8oQ1C0EJ2z0kqt3YYLgKIxL28blC_i2Q_5iIkNXGMVXvRPfE-q2lWMWRV7nZKkR77C3wEjvZCfcdP81W8g_3VMi11XSFDN-mSTHREzE8Tp1GfnRBhYVht6zg8nh5uMZIrUtBppktZYVyyEYg25BkTdGBf1CSF0Jg6E5Qkb-bdj6AsfhF59KYufLW_rWNpCKzuPtsQmMZUNwiYjmwZhNoaFNDueAIPJznprPULObXLUY8E826qqe6nRrZiLPRNQq9F7d4iXW4pPYLk5zoy0ZB-a6WGKE5ChalsWWjAqJcgZ7qd4R-Y-8d8VIREUNWftsbnV5BQf-USuayy2nkL5L0Yo9X5wNDHIhJkGFlwqa7LX-WorBFgAya&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUa470AkWsCye1ouQoujjbTFJRBGX7P1A5GTrRhK2xI7rBB1bYEmu42iDyLTcmH0r5yG8DhFhgT_JPLn2o7jNnF7TwV3XWPByihyaXWdjX5cCDhgTof-gdGYnxzdf-pmnH1Kj2_eQOngoGufAq0MJB1Z2Y1CK45KArreUEMuu4BWkSyU1Fu1ITIa3rQ8EumOG3ilbMvr4Md20ka8oQ1C0EJ2z0kqt3YYLgKIxL28blC_i2Q_5iIkNXGMVXvRPfE-q2lWMWRV7nZKkR77C3wEjvZCfcdP81W8g_3VMi11XSFDN-mSTHREzE8Tp1GfnRBhYVht6zg8nh5uMZIrUtBppktZYVyyEYg25BkTdGBf1CSF0Jg6E5Qkb-bdj6AsfhF59KYufLW_rWNpCKzuPtsQmMZUNwiYjmwZhNoaFNDueAIPJznprPULObXLUY8E826qqe6nRrZiLPRNQq9F7d4iXW4pPYLk5zoy0ZB-a6WGKE5ChalsWWjAqJcgZ7qd4R-Y-8d8VIREUNWftsbnV5BQf-USuayy2nkL5L0Yo9X5wNDHIhJkGFlwqa7LX-WorBFgAya%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw3unyARvPcLJkHFCNB7nlWr">Weekly Influenza &amp; Respiratory Activity: Statistics</a> report (containing influenza and RSV trends) and the <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUasw_g8RFpAZNR9-8eH94yS8CZ6xh2X8BTOyCVlZdyRBBRrXwHLibLl2TSHSiVINjw4TGibQiTZd8NNdXTYL5KOjURU9nZVaE1nHTRodDwf9p1SSR4-HKKY_fnt9ARzcimJOb3-xFrU6wuKM7veRBBQw==&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUasw_g8RFpAZNR9-8eH94yS8CZ6xh2X8BTOyCVlZdyRBBRrXwHLibLl2TSHSiVINjw4TGibQiTZd8NNdXTYL5KOjURU9nZVaE1nHTRodDwf9p1SSR4-HKKY_fnt9ARzcimJOb3-xFrU6wuKM7veRBBQw%3D%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw1OK0gmRFiz3zhrMxEJ_Z-x">COVID-19 Situation Update</a> will continue to be updated weekly and there will be a link to those sites from the new page. Each page will be updated weekly on Thursday at 11 a.m.
If you would like to receive email reminders when the pages are updated, subscribe to <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaywbqSkSxtfwUHk8U7fDyPg51l16zEuIiMILg1_mbcwXoIhsZMtZmD6OQGTnzF9y-FljotHDdyDQNdpd0vpxOWvXDpryFH8iA8ookyM4N0wRHwq87NKHrrPtomDYPW-_kCC3KIU06N_w2_u-j0D00SRMV_A4UObAuq20icT1-TJ0=&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaywbqSkSxtfwUHk8U7fDyPg51l16zEuIiMILg1_mbcwXoIhsZMtZmD6OQGTnzF9y-FljotHDdyDQNdpd0vpxOWvXDpryFH8iA8ookyM4N0wRHwq87NKHrrPtomDYPW-_kCC3KIU06N_w2_u-j0D00SRMV_A4UObAuq20icT1-TJ0%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw3_NkFTtj2aJaLh8VRu2NbL">Respiratory Illness Activity in Minnesota</a><a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaywbqSkSxtfwUHk8U7fDyPg51l16zEuIiMILg1_mbcwXoIhsZMtZmD6OQGTnzF9y-FljotHDdyDQNdpd0vpxOWvXDpryFH8iA8ookyM4N0wRHwq87NKHrrPtomDYPW-_kCC3KIU06N_w2_u-j0D00SRMV_A4UObAuq20icT1-TJ0=&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaywbqSkSxtfwUHk8U7fDyPg51l16zEuIiMILg1_mbcwXoIhsZMtZmD6OQGTnzF9y-FljotHDdyDQNdpd0vpxOWvXDpryFH8iA8ookyM4N0wRHwq87NKHrrPtomDYPW-_kCC3KIU06N_w2_u-j0D00SRMV_A4UObAuq20icT1-TJ0%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw3_NkFTtj2aJaLh8VRu2NbL">.</a>

Webpage Provides One-Stop Look at Viral Respiratory Disease Data

The Minnesota Department of Health Immunization Program shared the following letter with MNAAP in an effort to keep pediatricians up-to-date on the status of nirsevimab supplies:
The Centers for Disease Control and Prevention (CDC) alerted the Minnesota Department of  Health (MDH) that the supply of nirsevimab cannot keep up with demand. Please review MDH’s Health Alert Network (HAN) for background information and interim CDC recommendations that apply to healthcare settings with limited nirsevimab availability during the 2023–2024 RSV season <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaVd2y4uH-KcLDiFp9B9gQe1jaRk1TTTnmtaM3Ng2Z_ROA2BOohII6Hh5FpMLF9SiWlQyPY-gHGC_KvNVeQMXXNcJxf4XvfCIktMub2hnsZW1fPB0Cfj0bnzy4nSweXGZqqMpnXyqRGG8OX1S_ZI_40g==&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaVd2y4uH-KcLDiFp9B9gQe1jaRk1TTTnmtaM3Ng2Z_ROA2BOohII6Hh5FpMLF9SiWlQyPY-gHGC_KvNVeQMXXNcJxf4XvfCIktMub2hnsZW1fPB0Cfj0bnzy4nSweXGZqqMpnXyqRGG8OX1S_ZI_40g%3D%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723207000&amp;usg=AOvVaw2jI_5RWzLGmjbuvgLuq7kI">Health Advisory: Nirsevimab for RSV Prevention &#8211; Supply Issues (state.mn.us). </a>
Background
There are now two available products to protect infants from severe lower respiratory tract  infection caused by the respiratory syncytial virus (RSV):
• RSVpreF (vaccine) recommended for pregnant people who are 32 through 36 weeks  gestation during September through January. Abrysvo is the only approved product for  pregnant people.
• Nirsevimab (monoclonal antibody) recommended for all infants aged &lt;8 months born  during or entering their first RSV season and for some infants and children 8-19 months of age at increased risk of severe disease entering their second season.
Either product, but not both, can be chosen as a protection strategy. The Advisory Committee on Immunization Practices (ACIP) has not made a preference on either option.
Providers who care for pregnant persons should discuss the benefits and risks of both options,  preferably before the pregnant person reaches 32 weeks gestation. CDC’s <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUauxmMPRtDpDh25X_84zCk9ooIbF5v-sWsB0Y3z1FQ76s0w3X-qEBMgjSqleDYSOY1iy5kb0ySdi4wkZEybqZCjp1pqKQiafrsKYcPLK_ZzVIsXNMpMY08ssDmSiSYRlI5AJe2sdIR-tG-UFuN8SpNJk_jJH6H1rYTecae1t4vZk0=&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUauxmMPRtDpDh25X_84zCk9ooIbF5v-sWsB0Y3z1FQ76s0w3X-qEBMgjSqleDYSOY1iy5kb0ySdi4wkZEybqZCjp1pqKQiafrsKYcPLK_ZzVIsXNMpMY08ssDmSiSYRlI5AJe2sdIR-tG-UFuN8SpNJk_jJH6H1rYTecae1t4vZk0%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw3d47rc-9K9etoZwi49WjZ6">Options for Infant  RSV Prevention At-a-Glance</a> may be helpful. Information on the temporary shortage of nirsevimab should be considered when determining which product is best to protect the infant.
Under the Affordable Care Act, commercial payors have one year from ACIP recommendation to cover the vaccine for their members. This means your patients will need to check with their insurance to see if they have coverage for RSVpreF as the product was just recommended for use in September. Minnesota Health Care Programs (MHCPs) currently cover the product for pregnant people on their plans.
To support timely and accurate decision-making at the time of birth, please document vaccine administration or refusal in the pregnant person’s chart. If RSVpreF is administered to the pregnant person, please enter that dose into the Minnesota Immunization Information Connection (MIIC) in a timely manner. The MIIC forecaster/scheduler cannot predict or recommend the RSV vaccine for pregnant people because MIIC cannot track pregnancy status.
CDC recommends that all infants are protected against RSV through either maternal vaccination with RSVpreF or infant immunization with nirsevimab. Refer to the current <a href="https://r20.rs6.net/tn.jsp?f=001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaYgg6lq9_NsXlZpl8um0dty8cn-qjgAql5DI1aCvZHOfBLML7g1gCNkE1yHrU7qZKnGPWWag3wSFOkhNthP1qM-xJ3TFEXIGby_7rLba-D4RaVTWaKWo01BO3s2HiFO8cD5tv2Q98TiwMyCfPaBMaGw==&amp;c=1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw==&amp;ch=W0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001EiCtSR1KI9vf9k8PnFzcGH-yIaV1dABz_R1L6N7qyc6TxDbKD4DpcCJy1wKGryUaYgg6lq9_NsXlZpl8um0dty8cn-qjgAql5DI1aCvZHOfBLML7g1gCNkE1yHrU7qZKnGPWWag3wSFOkhNthP1qM-xJ3TFEXIGby_7rLba-D4RaVTWaKWo01BO3s2HiFO8cD5tv2Q98TiwMyCfPaBMaGw%3D%3D%26c%3D1OrCP1x5BWTxwVBQ9Bo51A-ppVR1IjAvnmThCpBX7E4rpXimK2utFw%3D%3D%26ch%3DW0l5HrO34widOpi7UWznUCzb-OaSUzcjHaXOkySf-BBeiROZTZVXdA%3D%3D&amp;source=gmail&amp;ust=1699541723208000&amp;usg=AOvVaw1CKRb2JA_RVySaodSTgf3J">RSV ACIP Vaccine  Recommendations</a> for details.

MDH Shares Information Regarding Nirsevimab Supply

Minnesota Department of Human Services (DHS) is seeking applications from new members for the EIDBI advisory group, which advises DHS on a health benefit for people younger than 21 years old with autism spectrum disorder (ASD) and related conditions.
Advisory group terms are two years and begin in January 2024. The EIDBI advisory group holds quarterly virtual meetings. The advisory group will have openings for members in January 2024, including one opening for a physician or developmental pediatrician.
Refer to <a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqRoDSmZN1YBnkVJfkWaDgFzrjA36nf0jHTR0Ba21Si2v3nCH3_sSXcDt9N91300UYJ75BuVSWV8Ce-wwAR_d8GsDvZkszo0gUd9mTEsfUY-G52NRPdLq1y980IbJDqzqCGqyTa9Qrdn-lSgxwYK6EM7KJ9Y3sBv1gmxWzMkZFEiZI4gSMsWmAhvrs0LLPfk2URX9lXMg7PcotyQUheAwWQoEZGmYDX6jv2YVUIlLv0uzryWVtZcdOyVC5pQEbtuwmW1lpGYmdF42NVN92ttJAtWF6FkCj3-B9ORJCwnFcuhk-3tZTI7xV6TeAE3D253XYjcIx3ByaFSusOg1NfIdKzyM3wINhCMs0p3WvuMT7AzMVAbS2AsLfw7hMm-e-lYGxCichMPCxqW6RiZUVYlKbwzMKNHXfd3rSvpfxQic7hKJQCO8pfc_pDgBszW58bqglhbJGb3B_cCPRPXckpbp3l01hWQORkxpHCqaTmRnq-hoU-PXO-v0sWLdmnUPoFld7avvEGHS_IVH6e6TqtqdHLqca9rhGWFuTISrhCP-D7wGbazOEJ0Wp8CTuhWOmguLBKHhlWi3ok1M=&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqRoDSmZN1YBnkVJfkWaDgFzrjA36nf0jHTR0Ba21Si2v3nCH3_sSXcDt9N91300UYJ75BuVSWV8Ce-wwAR_d8GsDvZkszo0gUd9mTEsfUY-G52NRPdLq1y980IbJDqzqCGqyTa9Qrdn-lSgxwYK6EM7KJ9Y3sBv1gmxWzMkZFEiZI4gSMsWmAhvrs0LLPfk2URX9lXMg7PcotyQUheAwWQoEZGmYDX6jv2YVUIlLv0uzryWVtZcdOyVC5pQEbtuwmW1lpGYmdF42NVN92ttJAtWF6FkCj3-B9ORJCwnFcuhk-3tZTI7xV6TeAE3D253XYjcIx3ByaFSusOg1NfIdKzyM3wINhCMs0p3WvuMT7AzMVAbS2AsLfw7hMm-e-lYGxCichMPCxqW6RiZUVYlKbwzMKNHXfd3rSvpfxQic7hKJQCO8pfc_pDgBszW58bqglhbJGb3B_cCPRPXckpbp3l01hWQORkxpHCqaTmRnq-hoU-PXO-v0sWLdmnUPoFld7avvEGHS_IVH6e6TqtqdHLqca9rhGWFuTISrhCP-D7wGbazOEJ0Wp8CTuhWOmguLBKHhlWi3ok1M%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358438000&amp;usg=AOvVaw2IgC08csJSjP5mGpRCpBTI">EIDBI benefit</a> or <a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqJBEZaoQvnThb5TKVg5eRBrVxk2ykMMKQbwV1fi1Pv0zBOrnpZGtwjrdPB_1fNh1lMiHKYw3E7FcAMOha5g8EMFdf_oz5xUVTm0K3sOnhSO0dVz_zUa3ml8IqQhok6awnLok-GAvY5H3ToarrKdJoV7BISgznDVSFllBkys1x9QEDj4tDeadqm-sx4O-S5bzN6-n7e0Ft0X_bsJGtcAVHL7rqucXWPJWohOchOztIL83lPCpqApXuYNMk_4o_6z7ItalfU0mhmiaTKV8a9fXhs9K_pyJFdR41_tk0vBzwNxSvcbN839tVb-Tu9upkBLNPDw8Doc-TNBV67JshcPEZbjHUEMRuP5J7blPmWEf5hp7NxrYpCIPXsez3k3JKSBWUGfQY2ZS6Hb-mV1ENHoNfLOOFFHx5kwA_YOF4eWFUkOt6V7_RM5KMC7V3cQ1IyLgiLUYcpQndoqWVXUO9sfqrhzNCjhgjTGBTlw3Yv8rYf0y-KLN3BAuZsoewG0El89np8fYbO9vzu73Km7yLucny_z5PlnDpTMndFWzZd0XfvIzaM9-R9gzXI7q0tzbfyvLhbOM8hN_SU2dHjpoMvzR4NO8eZJk0fPo5&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqJBEZaoQvnThb5TKVg5eRBrVxk2ykMMKQbwV1fi1Pv0zBOrnpZGtwjrdPB_1fNh1lMiHKYw3E7FcAMOha5g8EMFdf_oz5xUVTm0K3sOnhSO0dVz_zUa3ml8IqQhok6awnLok-GAvY5H3ToarrKdJoV7BISgznDVSFllBkys1x9QEDj4tDeadqm-sx4O-S5bzN6-n7e0Ft0X_bsJGtcAVHL7rqucXWPJWohOchOztIL83lPCpqApXuYNMk_4o_6z7ItalfU0mhmiaTKV8a9fXhs9K_pyJFdR41_tk0vBzwNxSvcbN839tVb-Tu9upkBLNPDw8Doc-TNBV67JshcPEZbjHUEMRuP5J7blPmWEf5hp7NxrYpCIPXsez3k3JKSBWUGfQY2ZS6Hb-mV1ENHoNfLOOFFHx5kwA_YOF4eWFUkOt6V7_RM5KMC7V3cQ1IyLgiLUYcpQndoqWVXUO9sfqrhzNCjhgjTGBTlw3Yv8rYf0y-KLN3BAuZsoewG0El89np8fYbO9vzu73Km7yLucny_z5PlnDpTMndFWzZd0XfvIzaM9-R9gzXI7q0tzbfyvLhbOM8hN_SU2dHjpoMvzR4NO8eZJk0fPo5%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358438000&amp;usg=AOvVaw3NNe06r9jmWhZeNcLOCiym">EIDBI advisory group</a> webpages for more information about EIDBI or the advisory group.
Submit your application between now and Nov. 8, 2023, through the <a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqlS-Yy3bLc5HH2Pr98VROGnl8iUcmjlu5QWlD5Y3uXKZex6B_aWez0I8_kesiJ38tvuZkeLeuG71UaEWyd76ZOf1hG970lArU58na_GIANX5tFi2HmhvJq9cfplViqMM9OVxcFwOyZYJGNweLnqXPG8dX0pSMf8MdaFpyRqf6ozN_kf-_yFY2_WH9JDwgU8NzBodE6J1qPtDSLB-SFgC0CgY9OJvb4H8iAmPHJrXUvCe-IK-fjMQ28DqsTUHUUDoMXSR707EMmWtavscaNsg5SZduxPd2G4LtfgFTI5iexs_e5fnWUleNCsNdn-yvDynd_3o59Tp0TSbY2TxOYPfJAnPkxolIyRuJG6xIzmxBg_v_sB5H9iFfVXUMLisIM8-JTeaDWEr-_0w4TqiWJdizmcw5cZc1BWYqFF1rqpHqTEG0InjMc2FBpFu-9IyPq6OjIzKJq_Amzadwcluui50D-gXU5ItoAyfj&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqlS-Yy3bLc5HH2Pr98VROGnl8iUcmjlu5QWlD5Y3uXKZex6B_aWez0I8_kesiJ38tvuZkeLeuG71UaEWyd76ZOf1hG970lArU58na_GIANX5tFi2HmhvJq9cfplViqMM9OVxcFwOyZYJGNweLnqXPG8dX0pSMf8MdaFpyRqf6ozN_kf-_yFY2_WH9JDwgU8NzBodE6J1qPtDSLB-SFgC0CgY9OJvb4H8iAmPHJrXUvCe-IK-fjMQ28DqsTUHUUDoMXSR707EMmWtavscaNsg5SZduxPd2G4LtfgFTI5iexs_e5fnWUleNCsNdn-yvDynd_3o59Tp0TSbY2TxOYPfJAnPkxolIyRuJG6xIzmxBg_v_sB5H9iFfVXUMLisIM8-JTeaDWEr-_0w4TqiWJdizmcw5cZc1BWYqFF1rqpHqTEG0InjMc2FBpFu-9IyPq6OjIzKJq_Amzadwcluui50D-gXU5ItoAyfj%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358438000&amp;usg=AOvVaw1Y-LpZlU_-Ku1-NaKnY_VT">Secretary of State Boards and Commissions – Open Positions</a> webpage to apply for a position.

Members Needed for the Early Intensive Developmental and Behavioral Intervention Advisory Group

If you were unable to attend the AAP Webinar: Nirsevimab Implementation Strategies in Outpatient Pediatric Practices, a replay link is now available <a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqCeXaBJV4Mwl_KX9szZHqULkcnXuW3b7p9Wns0yZTAfjtW0-9qfO79K9n7mr1CHDtGGyADcNFCqxeGvyHLs9xKP10DtDV5Lahla4pRulXJntEvMNNNJextboK6hKJ6vTjvx99hH63yQ1nAiTk9CMeh3eELJJEw8pEfTWuj6zKvm61netIBeTem5nQzp84e1uPJ2E_i3VFoDruj5PcJbZtmA==&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqCeXaBJV4Mwl_KX9szZHqULkcnXuW3b7p9Wns0yZTAfjtW0-9qfO79K9n7mr1CHDtGGyADcNFCqxeGvyHLs9xKP10DtDV5Lahla4pRulXJntEvMNNNJextboK6hKJ6vTjvx99hH63yQ1nAiTk9CMeh3eELJJEw8pEfTWuj6zKvm61netIBeTem5nQzp84e1uPJ2E_i3VFoDruj5PcJbZtmA%3D%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw2L65lzXQ0V7GC1JRJRySnq">here</a>. Below are links to the resources that were shared as well:
<ul>
<li><a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqq_LWdSnfBtmulTaWfkRi5JbHPVK89SqUcSkHjH-xWzX0G-YqB2UeC1VYO3X0jjCGVL-uq1wKQMO9cZNtP1JujxtpXgrzkQtFP7uYQXMs6K6DlGhk80V5IT--G-6OCSEdJPpURw1sxFZtrI7ikDTyusIQIJO03ilesl47ylIPQGI=&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqq_LWdSnfBtmulTaWfkRi5JbHPVK89SqUcSkHjH-xWzX0G-YqB2UeC1VYO3X0jjCGVL-uq1wKQMO9cZNtP1JujxtpXgrzkQtFP7uYQXMs6K6DlGhk80V5IT--G-6OCSEdJPpURw1sxFZtrI7ikDTyusIQIJO03ilesl47ylIPQGI%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw0-TOgIJeSoeBxXTvzoWDwy">Practice Readiness Checklist</a>: Use this checklist to assess your practice’s readiness to administer nirsevimab to patients.</li>
<li><a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqLzoWOeclZdw_5uu6_Bfj4bUeq6y50Ovy5vd2tPzcDd2hA-2yZzL2kB2y_ZWej2qDF2YqTL4YLksHZ4dbhbt45KrHhlfTTuU8np4FLA8zFyCV6dQQAaZ1lRudClIDYUDUwni98b2ZiZwtRj5Bu0JdblHjV3qhdKlb&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqLzoWOeclZdw_5uu6_Bfj4bUeq6y50Ovy5vd2tPzcDd2hA-2yZzL2kB2y_ZWej2qDF2YqTL4YLksHZ4dbhbt45KrHhlfTTuU8np4FLA8zFyCV6dQQAaZ1lRudClIDYUDUwni98b2ZiZwtRj5Bu0JdblHjV3qhdKlb%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw3jGaiHBQlJcz09V31gzmYj">Nirsevimab Implementation Guide</a>: Use this guide as you roll out nirsevimab to patients.</li>
<li><a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqHOC3zfyZX0Y3MR1xtRvG1n4t8q6e0obuqQo1EVU49hU6EODJG9Ng682ycu0QUrJEX9SB1sEUe01lZFAEfb25f4nZM9XN04ZeM5Fj2dRFi0IrT-g8IITcVNauV7RKbKKeCUiyNPprH2qq0Y0PFjvPuw==&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqHOC3zfyZX0Y3MR1xtRvG1n4t8q6e0obuqQo1EVU49hU6EODJG9Ng682ycu0QUrJEX9SB1sEUe01lZFAEfb25f4nZM9XN04ZeM5Fj2dRFi0IrT-g8IITcVNauV7RKbKKeCUiyNPprH2qq0Y0PFjvPuw%3D%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw3Fg4vlgudIicQxeqFE5cvU">Nirsevimab Administration Visual Guide</a>: Use this algorithm/guide to help determine if and what dose is needed for administration.</li>
<li><a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqWRdhnUB4JoKXSjP47j7JiRtcS6lSBaqWHyym6ithILMaNeNtYZxBqy-QDpYSoau-k_AKasCYeDeVLt256s1l_-mYC5Z3jFHw6SjlkoMkgbZNdoWmjYvHhgi3HJs1Zkrzg6YOFTqTmPZSbo36gj-mdSqbMAt9qL23qZMuHQ2Cyac=&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqWRdhnUB4JoKXSjP47j7JiRtcS6lSBaqWHyym6ithILMaNeNtYZxBqy-QDpYSoau-k_AKasCYeDeVLt256s1l_-mYC5Z3jFHw6SjlkoMkgbZNdoWmjYvHhgi3HJs1Zkrzg6YOFTqTmPZSbo36gj-mdSqbMAt9qL23qZMuHQ2Cyac%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw3-awUoGr0Tix6HE2MuLTjR">Immunization Information Statemen</a>t: Provide this VIS-like information to parents/caregivers when administering nirsevimab.</li>
<li><a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqs6qbokNLA6sOVc0765Vs6G2QqYyoJXWxA7l1RNnho07MZapfhLX-UGKE4ld_MS6pU7r4zrkLkdpg_r04S7N1KMBWaldl1EbDNf1a8WDS72TP4GwIGFBm5dCdvil_vYJvVl0gelDHlJQq5ZPh0Fmcl57RwkaKrIInyQZbCmIu4qWhMuK7USolJVZr4xr-b1ZCUAX86EZr_20=&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqs6qbokNLA6sOVc0765Vs6G2QqYyoJXWxA7l1RNnho07MZapfhLX-UGKE4ld_MS6pU7r4zrkLkdpg_r04S7N1KMBWaldl1EbDNf1a8WDS72TP4GwIGFBm5dCdvil_vYJvVl0gelDHlJQq5ZPh0Fmcl57RwkaKrIInyQZbCmIu4qWhMuK7USolJVZr4xr-b1ZCUAX86EZr_20%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw1ZBzGMjephO3ge32wEIDKs">Coding Guidance</a>: Find information about the CPT codes for nirsevimab and its administration, including coding vignettes.</li>
<li><a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqxEojsfE2pdLOk7V_d-_iIGPdQhSotkQAyLEXFFSdIDsKucpgbIv3NVkE9Ys63TDs1RUzVt-TXFXlT1mrM25FAT6IQV4DojqmHR6T0KqndrKzBh412_WQAldfz7CID9cZpLAlwLsRB-M2Qx6sPmAjrtoqV4nIXQRxxij4B4KrBX8RJfpq_uhkMSa-BXsZ6MxA8dzRfV53es8xBZDjHYr-UQ==&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqxEojsfE2pdLOk7V_d-_iIGPdQhSotkQAyLEXFFSdIDsKucpgbIv3NVkE9Ys63TDs1RUzVt-TXFXlT1mrM25FAT6IQV4DojqmHR6T0KqndrKzBh412_WQAldfz7CID9cZpLAlwLsRB-M2Qx6sPmAjrtoqV4nIXQRxxij4B4KrBX8RJfpq_uhkMSa-BXsZ6MxA8dzRfV53es8xBZDjHYr-UQ%3D%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw0aTkAS5nJX48OSjl1K_Pju">Nirsevimab FAQs</a>: Find answers to common questions about nirsevimab and administering it to patients. This page also includes a link to submit unanswered questions.</li>
</ul>
AAP News Article, “<a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqURwTt6iRv_IzBLRSdWEgnXP5cfMdAGWSJxgyM-UUPivyQbaKzPic2oCRKE3HVw4EpgbLkdsOB1uJmr0Y3Ndyy3TCLwwTlMt9xMzPEr5SdQptquU7Sgz2Fft7zSmTXKrO3tRN7l4CPBGpptowV5GDIcLJdjcnLAOs0IN_0akufZ5DSuKibY0GuBbxBG44_NBzg740T6qXyLc2tYdEHAzGtg==&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiqURwTt6iRv_IzBLRSdWEgnXP5cfMdAGWSJxgyM-UUPivyQbaKzPic2oCRKE3HVw4EpgbLkdsOB1uJmr0Y3Ndyy3TCLwwTlMt9xMzPEr5SdQptquU7Sgz2Fft7zSmTXKrO3tRN7l4CPBGpptowV5GDIcLJdjcnLAOs0IN_0akufZ5DSuKibY0GuBbxBG44_NBzg740T6qXyLc2tYdEHAzGtg%3D%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw2MFjealicJVNjAUu1WQiBJ">Supply issues plague nirsevimab ordering</a>” (October 17, 2023)
AAP Chapter Immunization Representative: To locate your state’s CIR, please submit an inquiry to the <a href="https://r20.rs6.net/tn.jsp?f=001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiql-31agLNX1jwofyEjXQ2p5_kZKEbOV7cGaAe8ikY1sML2H0J6UFjVPgPkgCXKqpa5N8bv335Uhhzz6D7MpvzAiDvnfw5S86p_-4TxzDZn1BxCM5h8dGPlSpiQDtG4yehaXN5pRaP9fU=&amp;c=spcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ==&amp;ch=34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA==" target="_blank" rel="noopener noreferrer" data-saferedirecturl="https://www.google.com/url?q=https://r20.rs6.net/tn.jsp?f%3D001Sh6_atdxglG5B9JP7c1M3ZFDWHovOYHhTyDGcZSiUhKqXpxYgLntigej8WteVEiql-31agLNX1jwofyEjXQ2p5_kZKEbOV7cGaAe8ikY1sML2H0J6UFjVPgPkgCXKqpa5N8bv335Uhhzz6D7MpvzAiDvnfw5S86p_-4TxzDZn1BxCM5h8dGPlSpiQDtG4yehaXN5pRaP9fU%3D%26c%3DspcFgfr7o-ko2MighpvUxu2LV39Aopy6AYFS9J6lqI545fQlFxxRpQ%3D%3D%26ch%3D34Fut_4e2HlasK6IVyO6RZ5Xxsd6V5ntr07mGaeSVtUXeAutrLwfjA%3D%3D&amp;source=gmail&amp;ust=1698157358437000&amp;usg=AOvVaw2GWtL3EzLk5cGCfA5Yn0i7">Immunization FAQ Submission Form</a>

Replay Link Available for Nirsevimab Implementation Webinar

Grand Itasca Clinic & Hospital is seeking a board certified/board eligible outpatient Pediatric Physician to join our busy and growing primary care clinic practice. Grand Itasca is a fully integrated multi-specialty clinic and hospital located in Grand Rapids, Minnesota.

Pediatric Physician

Partners in Pediatrics, Ltd. is seeking a full time BC/BE Pediatrician. The standard work week for a full-time pediatrician is 4 days a week plus a rotation of nights and weekends. Night and weekend shifts are shared equally among all providers. The salary package is competitive. You will have paid time off (PTO) and be given a CME allowance as well as CME days to further your medical education. We offer health, dental, disability and life insurance. You will also be eligible for a lucrative profit sharing 401(k). For inquiries, please contact our recruiting leads, Dr. Lisa Irvin at lirvin@pipstop.com and Dr. Megan Camerino at mcarmerino@pipstop.com

BC/BE Pediatrician

We’re excited to announce an opening for a Communications Manager at the Minnesota Chapter of the American Academy of Pediatrics (MNAAP). This part-time, remote role is a unique opportunity for a communications professional with at least five years of experience, who is passionate about advancing child health through advocacy, education, and special projects.